Published in Neurology on January 11, 2012
Screening for predementia AD: time-dependent operating characteristics of episodic memory tests. Neurology (2013) 1.75
Clinical utility of cerebrospinal fluid biomarkers in the diagnosis of early Alzheimer's disease. Alzheimers Dement (2014) 1.28
Heart-type fatty acid binding protein and vascular endothelial growth factor: cerebrospinal fluid biomarker candidates for Alzheimer's disease. Eur Arch Psychiatry Clin Neurosci (2013) 0.99
Memory loss in Alzheimer's disease. Dialogues Clin Neurosci (2013) 0.94
Revolutionizing Alzheimer's disease and clinical trials through biomarkers. Alzheimers Dement (Amst) (2015) 0.90
Plasma proteomics for the identification of Alzheimer disease. Alzheimer Dis Assoc Disord (2013) 0.85
CSF and clinical hallmarks of subcortical dementias: focus on DLB and PDD. J Neural Transm (Vienna) (2012) 0.81
Free and cued memory in relation to biomarker-defined abnormalities in clinically normal older adults and those at risk for Alzheimer's disease. Neuropsychologia (2015) 0.81
Drug development in Alzheimer's disease: the path to 2025. Alzheimers Res Ther (2016) 0.79
Short-term delayed recall of auditory verbal learning test is equivalent to long-term delayed recall for identifying amnestic mild cognitive impairment. PLoS One (2012) 0.79
Oxidative Stress and Its Clinical Applications in Dementia. J Neurodegener Dis (2012) 0.78
Optimizing Neuropsychological Assessments for Cognitive, Behavioral, and Functional Impairment Classification: A Machine Learning Study. Behav Neurol (2017) 0.77
Exploring anterograde memory: a volumetric MRI study in patients with mild cognitive impairment. Alzheimers Res Ther (2016) 0.77
Comparison of "Word" vs. "Picture" Version of the Free and Cued Selective Reminding Test (FCSRT) in Older Adults. Alzheimers Dement (Amst) (2015) 0.77
10-minute delayed recall from the modified mini-mental state test predicts Alzheimer's disease pathology. J Alzheimers Dis (2014) 0.76
Alzheimer disease: can the exam predict the pathology? Neurology (2012) 0.76
The free and cued selective reminding test distinguishes frontotemporal dementia from Alzheimer's disease. Arch Clin Neuropsychol (2014) 0.76
Fluorodeoxyglucose metabolism associated with tau-amyloid interaction predicts memory decline. Ann Neurol (2017) 0.76
The need for harmonisation and innovation of neuropsychological assessment in neurodegenerative dementias in Europe: consensus document of the Joint Program for Neurodegenerative Diseases Working Group. Alzheimers Res Ther (2017) 0.75
Identifying memory impairment and early dementia in primary care. Alzheimers Dement (Amst) (2017) 0.75
Low Cerebrospinal Fluid Amyloid-Beta Concentration Is Associated with Poorer Delayed Memory Recall in Women. Dement Geriatr Cogn Dis Extra (2016) 0.75
Cued memory decline in biomarker-defined preclinical Alzheimer disease. Neurology (2017) 0.75
Incremental value of biomarker combinations to predict progression of mild cognitive impairment to Alzheimer's dementia. Alzheimers Res Ther (2017) 0.75
A normative study of the Italian printed word version of the free and cued selective reminding test. Neurol Sci (2015) 0.75
On the path to 2025: understanding the Alzheimer's disease continuum. Alzheimers Res Ther (2017) 0.75
General cognitive status among Baby boomers and pre-boomers in Taiwan: the interplay between mid-life socioeconomic status and city residence. BMC Geriatr (2017) 0.75
Recalling feature bindings differentiates Alzheimer's disease from frontotemporal dementia. J Neurol (2017) 0.75
Inflammation and Alzheimer's disease. Neurobiol Aging (2000) 12.56
Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease. Nat Genet (2013) 9.46
Interleukin 12 is required for the T-lymphocyte-independent induction of interferon gamma by an intracellular parasite and induces resistance in T-cell-deficient hosts. Proc Natl Acad Sci U S A (1993) 6.87
THE MEASUREMENT AND RECORDING OF GASTRODUODENAL BLOOD FLOW IN MAN BY MEANS OF A THERMAL GRADIENTOMETER. J Clin Invest (1942) 5.96
The T-region of Ti plasmids codes for an enzyme synthesizing indole-3-acetic acid. Eur J Biochem (1984) 4.88
Familial colorectal cancer in Ashkenazim due to a hypermutable tract in APC. Nat Genet (1997) 4.86
Discrimination between Alzheimer dementia and controls by automated analysis of multicenter FDG PET. Neuroimage (2002) 3.88
Genome-wide association for major depressive disorder: a possible role for the presynaptic protein piccolo. Mol Psychiatry (2008) 3.85
Mortality among workers at Oak Ridge National Laboratory. Evidence of radiation effects in follow-up through 1984. JAMA (1991) 3.80
Erythropoietin prevents neuronal apoptosis after cerebral ischemia and metabolic stress. Proc Natl Acad Sci U S A (2001) 3.80
Disruption of ClC-3, a chloride channel expressed on synaptic vesicles, leads to a loss of the hippocampus. Neuron (2001) 3.51
Concomitant induction of phenylalanine ammonia-lyase and flavanone synthase mRNAs in irradiated plant cells. J Biol Chem (1979) 3.38
QT interval prolongation as predictor of sudden death in patients with myocardial infarction. Circulation (1978) 3.32
IL-12 increases resistance of BALB/c mice to Mycobacterium tuberculosis infection. J Immunol (1995) 3.29
Analysis of heterogeneous A4 peptides in human cerebrospinal fluid and blood by a newly developed sensitive Western blot assay. J Biol Chem (1996) 3.10
Mind reading: neural mechanisms of theory of mind and self-perspective. Neuroimage (2001) 3.03
Growth and transplantation of a custom vascularised bone graft in a man. Lancet (2004) 3.01
Longitudinal CSF and MRI biomarkers improve the diagnosis of mild cognitive impairment. Neurobiol Aging (2005) 3.00
Stroke in users of low-dose oral contraceptives. N Engl J Med (1996) 2.98
Recurrent BRCA2 6174delT mutations in Ashkenazi Jewish women affected by breast cancer. Nat Genet (1996) 2.93
Secondary plasmodesmata are specific sites of localization of the tobacco mosaic virus movement protein in transgenic tobacco plants. Plant Cell (1992) 2.91
Asbestos dust exposure during brake repair. Am J Ind Med (1986) 2.78
Association of germline mutation in the PTEN tumour suppressor gene and Proteus and Proteus-like syndromes. Lancet (2001) 2.77
Improved discrimination of AD patients using beta-amyloid(1-42) and tau levels in CSF. Neurology (1999) 2.74
Model of complications of NIDDM. II. Analysis of the health benefits and cost-effectiveness of treating NIDDM with the goal of normoglycemia. Diabetes Care (1997) 2.63
Stability increase of the lumbar spine with different muscle groups. A biomechanical in vitro study. Spine (Phila Pa 1976) (1995) 2.62
Ranibizumab (Lucentis) in neovascular age-related macular degeneration: evidence from clinical trials. Br J Ophthalmol (2009) 2.60
Sequence analysis of BRCA1 and BRCA2: correlation of mutations with family history and ovarian cancer risk. J Clin Oncol (1998) 2.55
Intensive livestock operations, health, and quality of life among eastern North Carolina residents. Environ Health Perspect (2000) 2.52
Fetal cells in the blood of pregnant women: detection and enrichment by fluorescence-activated cell sorting. Proc Natl Acad Sci U S A (1979) 2.45
Germline BRCA1 185delAG mutations in Jewish women with breast cancer. Lancet (1996) 2.40
Pericentric inversions of human chromosomes 9 and 10. Am J Hum Genet (1974) 2.40
Gene expression in papillary thyroid carcinoma reveals highly consistent profiles. Proc Natl Acad Sci U S A (2001) 2.38
Detection of 14-3-3 protein in the cerebrospinal fluid supports the diagnosis of Creutzfeldt-Jakob disease. Ann Neurol (1998) 2.35
Model of complications of NIDDM. I. Model construction and assumptions. Diabetes Care (1997) 2.32
Retinal microcirculation in patients with diabetes mellitus: dynamic and morphological analysis of perifoveal capillary network. Br J Ophthalmol (1991) 2.30
Epigenetic PTEN silencing in malignant melanomas without PTEN mutation. Am J Pathol (2000) 2.23
"Sniffin' sticks": screening of olfactory performance. Rhinology (1996) 2.17
The Hamilton scales and the Hopkins Symptom Checklist (SCL-90). A cross-national validity study in patients with panic disorders. Br J Psychiatry (1992) 2.16
Diagnosis of Creutzfeldt-Jakob disease by measurement of S100 protein in serum: prospective case-control study. BMJ (1998) 2.15
Intravenous immunoglobulins containing antibodies against beta-amyloid for the treatment of Alzheimer's disease. J Neurol Neurosurg Psychiatry (2004) 2.12
Clozapine rechallenge after an episode of 'neuroleptic malignant syndrome'. Br J Psychiatry (1992) 2.12
Net costs of dementia by disease stage. Acta Psychiatr Scand (2011) 2.11
Interleukin 12-mediated prevention of spontaneous mammary adenocarcinomas in two lines of Her-2/neu transgenic mice. J Exp Med (1998) 2.08
Meta-analysis of 32 genome-wide linkage studies of schizophrenia. Mol Psychiatry (2008) 2.07
Laparoscopic resection of gastric gastrointestinal stromal tumors (GIST) is safe and effective, irrespective of tumor size. Surg Endosc (2012) 2.04
CNTF and endogenous psychoses? Nat Genet (1996) 2.02
TMEM132D, a new candidate for anxiety phenotypes: evidence from human and mouse studies. Mol Psychiatry (2010) 2.00
Current practice of temporary vena cava filter insertion: a multicenter registry. J Vasc Interv Radiol (2000) 2.00
Mapping of the protein-coding regions of Rhizobium meliloti common nodulation genes. EMBO J (1984) 2.00
Effect of APOE genotype on amyloid plaque load and gray matter volume in Alzheimer disease. Neurology (2009) 1.99
Excess of high activity monoamine oxidase A gene promoter alleles in female patients with panic disorder. Hum Mol Genet (1999) 1.98
Genotype-phenotype relationship in female carriers of the premutation and full mutation of FMR-1. Psychiatry Res (1998) 1.95
Different preparation methods to obtain platelet components as a source of growth factors for local application. Transfusion (2001) 1.92
A 3.6-kbp segment from the vir region of Ti plasmids contains genes responsible for border-sequence-directed production of T region circles in E. coli. EMBO J (1986) 1.92
The conserved part of the T-region in Ti-plasmids expresses four proteins in bacteria. EMBO J (1983) 1.92
Molecular characterization and biological function of the movement protein of tobacco mosaic virus in transgenic plants. Proc Natl Acad Sci U S A (1990) 1.89
Body size and dispersal mode as key traits determining metacommunity structure of aquatic organisms. Ecol Lett (2012) 1.88
A precision measurement of the mass of the top quark. Nature (2004) 1.87
Molecular Analysis and Heterologous Expression of an Inducible Cytochrome P-450 Protein from Periwinkle (Catharanthus roseus L.). Plant Physiol (1992) 1.87
Germline and germline mosaic PTEN mutations associated with a Proteus-like syndrome of hemihypertrophy, lower limb asymmetry, arteriovenous malformations and lipomatosis. Hum Mol Genet (2000) 1.84
Subcortical correlates of craving in recently abstinent alcoholic patients. Am J Psychiatry (2001) 1.84
Tau protein and 14-3-3 protein in the differential diagnosis of Creutzfeldt-Jakob disease. Neurology (2002) 1.84
Nonunion of the mandible: an analysis of contributing factors. J Oral Maxillofac Surg (2000) 1.83
Management and outcome of patients with established coronary artery disease: the Euro Heart Survey on coronary revascularization. Eur Heart J (2005) 1.83
Retroviral RNA identified in the cerebrospinal fluids and brains of individuals with schizophrenia. Proc Natl Acad Sci U S A (2001) 1.82
Expressed sequences as candidates for a novel tumor suppressor gene at band 13q14 in B-cell chronic lymphocytic leukemia and mantle cell lymphoma. Oncogene (1998) 1.81
Germline mutations in BMPR1A/ALK3 cause a subset of cases of juvenile polyposis syndrome and of Cowden and Bannayan-Riley-Ruvalcaba syndromes. Am J Hum Genet (2001) 1.81
Transplacental passage of blood cells. J Med Genet (1975) 1.80
Proline residues in the HIV-1 NH2-terminal capsid domain: structure determinants for proper core assembly and subsequent steps of early replication. Virology (2000) 1.77
The founder mutation MSH2*1906G-->C is an important cause of hereditary nonpolyposis colorectal cancer in the Ashkenazi Jewish population. Am J Hum Genet (2002) 1.77
Risk factors for incident mild cognitive impairment--results from the German Study on Ageing, Cognition and Dementia in Primary Care Patients (AgeCoDe). Acta Psychiatr Scand (2009) 1.76
Morbidity of harvesting of bone grafts from the iliac crest for preprosthetic augmentation procedures: a prospective study. Int J Oral Maxillofac Surg (2004) 1.76
Neuropathic shoulder arthropathy (Charcot joint) associated with syringomyelia. Neurology (1998) 1.73
Elevated levels of tau-protein in cerebrospinal fluid of patients with Creutzfeldt-Jakob disease. Neurosci Lett (1997) 1.71
Structural control of polyketide formation in plant-specific polyketide synthases. Chem Biol (2000) 1.71
Evidence suggestive of a locus on chromosome 5q31 contributing to susceptibility for schizophrenia in German and Israeli families by multipoint affected sib-pair linkage analysis. Mol Psychiatry (1997) 1.66
Emergency physician workload: a time study. Ann Emerg Med (1993) 1.66
Tumour genes in plants: T-DNA encoded cytokinin biosynthesis. EMBO J (1985) 1.66
A worldwide multicentre comparison of assays for cerebrospinal fluid biomarkers in Alzheimer's disease. Ann Clin Biochem (2009) 1.66
Portosystemic hepatic encephalopathy after transjugular intrahepatic portosystemic shunt in patients with cirrhosis: clinical, laboratory, psychometric, and electroencephalographic investigations. Hepatology (1998) 1.65
Association between genetic variation in a region on chromosome 11 and schizophrenia in large samples from Europe. Mol Psychiatry (2011) 1.65
A universal spine tester for in vitro experiments with muscle force simulation. Eur Spine J (1994) 1.65
Functional connectivity of the fusiform gyrus during a face-matching task in subjects with mild cognitive impairment. Brain (2006) 1.62
Psychosocial work factors and dementia. Occup Environ Med (2004) 1.62
Validity of the five-item WHO Well-Being Index (WHO-5) in an elderly population. Eur Arch Psychiatry Clin Neurosci (2001) 1.62
Light-induced enzyme synthesis in cell suspension cultures of Petroselinum hortense. Demonstration in a heterologous cell-free system of rapid changes in the rate of phenylalanine ammonia-lyase synthesis. Eur J Biochem (1976) 1.62
A genetic variation of cathepsin D is a major risk factor for Alzheimer's disease. Ann Neurol (2000) 1.61
Search for supersymmetry using final states with one lepton, jets, and missing transverse momentum with the ATLAS detector in √s=7 TeV pp collisions. Phys Rev Lett (2011) 1.60
Combined assessment of tau and neuronal thread protein in Alzheimer's disease CSF. Neurology (2000) 1.60
Examination of G72 and D-amino-acid oxidase as genetic risk factors for schizophrenia and bipolar affective disorder. Mol Psychiatry (2004) 1.60
Evaluation of linkage of bipolar affective disorder to chromosome 18 in a sample of 57 German families. Mol Psychiatry (1999) 1.59
The Roseto effect: a 50-year comparison of mortality rates. Am J Public Health (1992) 1.58